Dekorationsartikel gehören nicht zum Leistungsumfang.
Sprache:
Englisch
251,50 €*
Versandkostenfrei per Post / DHL
Aktuell nicht verfügbar
Kategorien:
Beschreibung
The ESC Textbook of Heart Failure brings together renowned experts to present an up-to-date understanding of all aspects of this chronic condition. The clinically oriented work reflects guidelines and summarizes the latest evidence from clinical trials. A must read for cardiovascular healthcare specialists in Europe and across the world.
The ESC Textbook of Heart Failure brings together renowned experts to present an up-to-date understanding of all aspects of this chronic condition. The clinically oriented work reflects guidelines and summarizes the latest evidence from clinical trials. A must read for cardiovascular healthcare specialists in Europe and across the world.
Inhaltsverzeichnis
- Section 1: Universal definition of heart failure
- 1.1: Andrew JS Coats, Biykem Bozkurt and Petar M. Seferovic: Universal definition of heart failure
- Section 2: Epidemiology of heart failure
- 2.1: Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H Rutten: Epidemiology of heart failure
- Section 3: Etiology of heart failure
- 3.1: (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea: Coronary artery disease
- 3.2: Athanasios Manolis and Yuri Lopatin: Hypertension
- 3.3: Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano: Valvular heart disease
- 3.4.1: Thomas Thum, Stephane Heymans, and Johannes Backs: Genetic basis of cardiomyopathies
- 3.4.2: Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina: Dilated and hypokinetic non-dilated cardiomyopathy
- 3.4.3: Perry Elliott, Michel Noutsias and Aris Anastasakis: Hypertrophic cardiomyopathy
- 3.4.4: Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren: Restrictive cardiomyopathy
- 3.4.5: Cristina Basso, Hugh Calkins and Domenico Corrado: Arrhythmogenic right ventricular cardiomyopathy
- 3.4.6: Karen Sliwa and Johann Bauersachs: Peripartum cardiomyopathy
- 3.4.7: Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin: Takotsubo cardiomyopathy
- 3.5: Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio: Myocarditis and pericarditis
- 3.6: Werner Budts and Jolien Roos-Hesselink: Congenital heart disease
- 3.7: Martin Huelsmann, Jelena Seferovic and Francesco Cosentino: Endocrine and metabolic disorders
- 3.8: Lina Badimon, Stefan Anker and Stephan von Haehling: Obesity
- 3.9: Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez: Cancer and cancer therapy
- 3.10: Antonello Gavazzi, Maria Nunes, and Fausto Pinto: Toxins (e.g. alcohol etc.) and infections
- Section 4: Prevention of heart failure
- 4.1: Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley Zieroth: Prevention of heart failure
- Section 5: Pathophysiology of heart failure
- 5.1: (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs: Molecular and cellular mechanisms
- 5.2: Edoardo Bertero and Chistoph Maack: Alterations in myocardial metabolism
- 5.3: Javier Diez Martinez and Hans-Peter Brunner La Rocca: Ventricular remodelling
- 5.4: Antoni Bayes Gennis and Faiez Zannad: Neurohormonal activation
- 5.5: Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis: Immune-mediated mechanisms
- 5.6: Stephane Heymans: Inflammation, oxidative stress and endothelial dysfunction
- 5.7: Alterations in peripheral circulation and renal function (: Alterations in peripheral circulation and renal function
- 5.8: (Stephan von Haehling and Wolfram Doehner: Systemic adaptations in metabolism and nutritive status
- Section 6: Clinical phenotypes of chronic heart failure
- 6.1: Thomas Luscher, Petar Seferovic, and Brian Halliday: HFrEF
- 6.2: Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam: HFmrEF
- 6.3: Rudolf De Boer, Burkert Pieske, and Barry Borlaug: HFpEF
- 6.4: Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te Riele: Right heart failure
- Section 7: Chronic heart failure: diagnostic and prognostic assessment
- 7.1: Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto: Clinical assessment
- 7.2: Rudolf de Boer, Antioni Bayes Genis and James Januzzi: Biomarkers in diagnostic and prognostic assessment
- 7.3: Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax: Echocardiography
- 7.4: Danilo Neglia and Alessia Gimelli: Nuclear medicine
- 7.5: Stephan Achenbach and Amina Rakisheva: Cardiac computed tomography
- 7.6: Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci: Cardiac magnetic resonance
- 7.7: Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli: Cardiopulmonary exercise
- 7.8: Christian Hamm, Brigit Assmus and Veselin Mitrovic: Cardiac catheterization, invasive imaging and haemodynamic assessment
- Section 8: Chronic heart failure: pharmacological management
- 8.1: Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt: Angiotensin converting enzyme inhibitors
- 8.2: Ileana L. Pina and Magdy Abdelhamid: Angiotensin I receptor blockers
- 8.3: Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats: ARNI
- 8.4: Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra: Beta-blockers
- 8.5: Bertram Pitt, João Pedro Ferreira and Faiez Zannad: Mineralocorticoid receptor agonists
- 8.6: Michael Bohm and Michel Komajda: Ivabradine
- 8.7: Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa: Vasodilators
- 8.8: Udo Bavendiek and Johann Bauersachs: Digitalis glycosides
- 8.9: Jeroen Dauw, Stephen Gottlieb and Wifried Mullens: Diuretics
- 8.10: Jan Biegus, Piotr Ponikowski, and Christoph Maack: Inotropes and inodilators
- 8.11: Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi: SGLT2 inhibitors
- 8.12: Stefan Agewall, Isabelle van Gelder, and Irene Savelieva: Ancillary pharmacological treatment options
- 8.13: Giuseppe Rosano, Gerasimos Filippatos, and Randall Starling: New and emerging therapies
- Section 9: Chronic heart failure: non-pharmacological management
- 9.1: Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein: Implantable cardioverter defibrillator
- 9.2: Pieter Martens, Eva Goncalvesova, and Wilfried Mullens: Cardiac resynchronization therapy
- 9.3: Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk: Cardiac surgery
- 9.4: Stefan Orwat, Stefan Anker and Helmut Baumgartner: Valve interventions
- 9.5: Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham: Ancillary procedures
- 9.6: Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo Piepoli: Cardiac rehabilitation
- Section 10: Acute heart failure
- 10.1: Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip: Acute heart failure: diagnostic and prognostic assessment
- 10.2: Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre Mebazaa: Acute heart failure: management
- Section 11: Advanced heart failure
- 11.1: Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo: Advanced heart failure: assessment
- 11.2: Daniela Tomasoni, Marianna Adamo, and Marco Metra: Advanced heart failure: management
- 11.3: Mandeep Mehra and Finn Gustafsson: Mechanical circulatory support
- 11.4: Davor Milicic, Mandeep Mehra, and Randall Starling: Heart transplantation
- 11.5: Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna Strömberg: Palliative care and end-of-life management
- Section 12: Comorbidities and clinical conditions
- 12.1: Pieter Martens and Hans-Peter Brunner-La Rocca: Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure
- 12.2: Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira: Dyskalaemia
- 12.3: Josep Masip, Karina Portillo and Mattia Arrigo: Chronic lung disease
- 12.4: Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats: Ventilatory Abnormalities and Sleep Disordered Breathing
- 12.5: Irene M. Lang and Stephan Rosenkranz: Pulmonary hypertension
- 12.6: Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti: Cardiac rhythm disorders
- 12.7: Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer: Management of atrial fibrillation in heart failure
- 12.8: Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino: Diabetes, metabolic syndrome and endocrine disorders
- 12.9: Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic: Systemic immune medicated diseases
- 12.10: Yuri Lopatin and Gianluigi Savarese: Liver and gut dysfunction
- 12.11: Ewa Jankowska, Piotr Ponikowski, and Stefan Anker: Anaemia and iron deficiency
- 12.12: Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz: Depression and cognitive impairment
- 12.13: Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov: Cancer
- 12.14: Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa: Pregnancy
- 12.15: Ewa Jankowska, Cristiana Vitale and Dong-Ju Choi: Frailty
- Section 13: Self-care and patient education
- 13.1: Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina Hansen: Self-care and patient education
- Section 14: Multidisciplinary approach to heart failure management
- 14.1: Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine...
Details
| Erscheinungsjahr: | 2024 |
|---|---|
| Fachbereich: | Chirurgie |
| Genre: | Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Buch |
| Seiten: | 1040 |
| ISBN-13: | 9780198891628 |
| ISBN-10: | 0198891628 |
| Sprache: | Englisch |
| Einband: | Gebunden |
| Autor: |
Seferovic, Petar
Coats, Andrew Filippatos, Gerasimos Bauersachs, Johann Rosano, Giuseppe Anker, Stefan |
| Hersteller: | Oxford University Press, USA |
| Maße: | 277 x 244 x 66 mm |
| Von/Mit: | Petar Seferovic (u. a.) |
| Erscheinungsdatum: | 09.02.2024 |
| Gewicht: | 2,767 kg |
Inhaltsverzeichnis
- Section 1: Universal definition of heart failure
- 1.1: Andrew JS Coats, Biykem Bozkurt and Petar M. Seferovic: Universal definition of heart failure
- Section 2: Epidemiology of heart failure
- 2.1: Amy Groenewegen, Ivan Milinkovi?, Arno W Hoes, Arend Mosterd, Frans H Rutten: Epidemiology of heart failure
- Section 3: Etiology of heart failure
- 3.1: (Rocco Antonio Montone, Maurizio Volterrani, Jian Zhang and Filippo Crea: Coronary artery disease
- 3.2: Athanasios Manolis and Yuri Lopatin: Hypertension
- 3.3: Ana Pardo Sanz, Ivan Milinkovic and Josep Zamorano: Valvular heart disease
- 3.4.1: Thomas Thum, Stephane Heymans, and Johannes Backs: Genetic basis of cardiomyopathies
- 3.4.2: Petar M.Seferovic, Biykem Bozkurt, and Marija Polovina: Dilated and hypokinetic non-dilated cardiomyopathy
- 3.4.3: Perry Elliott, Michel Noutsias and Aris Anastasakis: Hypertrophic cardiomyopathy
- 3.4.4: Claudio Rapezzi, Alberto Aimo, Ales Linhart, and Andre Keren: Restrictive cardiomyopathy
- 3.4.5: Cristina Basso, Hugh Calkins and Domenico Corrado: Arrhythmogenic right ventricular cardiomyopathy
- 3.4.6: Karen Sliwa and Johann Bauersachs: Peripartum cardiomyopathy
- 3.4.7: Jelena Templin-Ghadri, Michael Würdinger, Johann Bauersachs, and Christian Templin: Takotsubo cardiomyopathy
- 3.5: Stephane Heymans, Arsen Risti?, Yehuda Adler, and Massimo Imazio: Myocarditis and pericarditis
- 3.6: Werner Budts and Jolien Roos-Hesselink: Congenital heart disease
- 3.7: Martin Huelsmann, Jelena Seferovic and Francesco Cosentino: Endocrine and metabolic disorders
- 3.8: Lina Badimon, Stefan Anker and Stephan von Haehling: Obesity
- 3.9: Alexander Lyon, Dimitrios Farmakis, Daniela Cardinale and Teresa Lopez Fernandez: Cancer and cancer therapy
- 3.10: Antonello Gavazzi, Maria Nunes, and Fausto Pinto: Toxins (e.g. alcohol etc.) and infections
- Section 4: Prevention of heart failure
- 4.1: Massimo Piepoli, Maria Benedetta Matrone, Paul Dendale, and Shelley Zieroth: Prevention of heart failure
- Section 5: Pathophysiology of heart failure
- 5.1: (Junjie Xiao, Thomas Thum, Gianluigi Condorelli and Johannes Backs: Molecular and cellular mechanisms
- 5.2: Edoardo Bertero and Chistoph Maack: Alterations in myocardial metabolism
- 5.3: Javier Diez Martinez and Hans-Peter Brunner La Rocca: Ventricular remodelling
- 5.4: Antoni Bayes Gennis and Faiez Zannad: Neurohormonal activation
- 5.5: Urlich Hofmann, Stefan Frantz and Nikolaos Frangogiannis: Immune-mediated mechanisms
- 5.6: Stephane Heymans: Inflammation, oxidative stress and endothelial dysfunction
- 5.7: Alterations in peripheral circulation and renal function (: Alterations in peripheral circulation and renal function
- 5.8: (Stephan von Haehling and Wolfram Doehner: Systemic adaptations in metabolism and nutritive status
- Section 6: Clinical phenotypes of chronic heart failure
- 6.1: Thomas Luscher, Petar Seferovic, and Brian Halliday: HFrEF
- 6.2: Adrian Voors, Brenda Moura, Lars Lund and Carolyn Lam: HFmrEF
- 6.3: Rudolf De Boer, Burkert Pieske, and Barry Borlaug: HFpEF
- 6.4: Thomas Luscher, Thomas M. Gorter, Susanna Price, Michael Gatzoulis and Anneline Te Riele: Right heart failure
- Section 7: Chronic heart failure: diagnostic and prognostic assessment
- 7.1: Michel Komajda, Piotr Ponikowski, and Evgeny Shlyakhto: Clinical assessment
- 7.2: Rudolf de Boer, Antioni Bayes Genis and James Januzzi: Biomarkers in diagnostic and prognostic assessment
- 7.3: Philippe Debonnaire, Victoria Delgado, Thor Edvardsen, Bogdan Popescu, and Jeroen Bax: Echocardiography
- 7.4: Danilo Neglia and Alessia Gimelli: Nuclear medicine
- 7.5: Stephan Achenbach and Amina Rakisheva: Cardiac computed tomography
- 7.6: Anna Baritussio, Noor Sharrack, Sven Plein, and Chiara Bucciarelli-Bucci: Cardiac magnetic resonance
- 7.7: Luca Moderato, Davide Lazzeroni, Stamatis Adamopoulos, Alain Cohen-Solal and Massimo Piepoli: Cardiopulmonary exercise
- 7.8: Christian Hamm, Brigit Assmus and Veselin Mitrovic: Cardiac catheterization, invasive imaging and haemodynamic assessment
- Section 8: Chronic heart failure: pharmacological management
- 8.1: Roberto Ferrari, Gabriele Guardigli, and Biykem Bozkurt: Angiotensin converting enzyme inhibitors
- 8.2: Ileana L. Pina and Magdy Abdelhamid: Angiotensin I receptor blockers
- 8.3: Petar M. Seferovic, Michele Senni, Marija Polovina and Andrew JS Coats: ARNI
- 8.4: Daniela Tomasoni, Marianna Adamo, Hiroyuki Tsutsui, and Marco Metra: Beta-blockers
- 8.5: Bertram Pitt, João Pedro Ferreira and Faiez Zannad: Mineralocorticoid receptor agonists
- 8.6: Michael Bohm and Michel Komajda: Ivabradine
- 8.7: Eftihia Polyzogopoulou, Maria Nikolaou, John Parissis and Alexandre Mebazaa: Vasodilators
- 8.8: Udo Bavendiek and Johann Bauersachs: Digitalis glycosides
- 8.9: Jeroen Dauw, Stephen Gottlieb and Wifried Mullens: Diuretics
- 8.10: Jan Biegus, Piotr Ponikowski, and Christoph Maack: Inotropes and inodilators
- 8.11: Petar M. Seferovic, Francesco Cosentino, Giuseppe Rosano and James Januzzi: SGLT2 inhibitors
- 8.12: Stefan Agewall, Isabelle van Gelder, and Irene Savelieva: Ancillary pharmacological treatment options
- 8.13: Giuseppe Rosano, Gerasimos Filippatos, and Randall Starling: New and emerging therapies
- Section 9: Chronic heart failure: non-pharmacological management
- 9.1: Gianluigi Savarese, Cecilia Linde and Kenneth Dickstein: Implantable cardioverter defibrillator
- 9.2: Pieter Martens, Eva Goncalvesova, and Wilfried Mullens: Cardiac resynchronization therapy
- 9.3: Felix Schoenrat, Franz-Josef Neumann, Miguel Sousa Uva and Volkmar Falk: Cardiac surgery
- 9.4: Stefan Orwat, Stefan Anker and Helmut Baumgartner: Valve interventions
- 9.5: Andrew JS Coats, Piotr P Ponikowski, Maria-Rosa Costanzo and William T. Abraham: Ancillary procedures
- 9.6: Maurizio Volterrani, Alain Cohen-Solal, Stamatis Adamopulos, Dimitris Miliopoulos, Ferdinando Iellamo, and Massimo Piepoli: Cardiac rehabilitation
- Section 10: Acute heart failure
- 10.1: Ovidiu Chioncel, Gerasimos Filippatos, Alexandre Mebazaa, Veli-Pekka Harjola, and Josep Masip: Acute heart failure: diagnostic and prognostic assessment
- 10.2: Katerina Fountoulaki, John Parissis, Sean Collins, Mehmet Birhan Yilmaz, and Alexandre Mebazaa: Acute heart failure: management
- Section 11: Advanced heart failure
- 11.1: Tuvia Ben Gal, Mariell Jessup, and Maria-Rosa Costanzo: Advanced heart failure: assessment
- 11.2: Daniela Tomasoni, Marianna Adamo, and Marco Metra: Advanced heart failure: management
- 11.3: Mandeep Mehra and Finn Gustafsson: Mechanical circulatory support
- 11.4: Davor Milicic, Mandeep Mehra, and Randall Starling: Heart transplantation
- 11.5: Tiny Jaarsma, Donna Fitzsimons, Lisa Hjelmfors, Loreena Hill, Ekaterini Lambrinou, and Anna Strömberg: Palliative care and end-of-life management
- Section 12: Comorbidities and clinical conditions
- 12.1: Pieter Martens and Hans-Peter Brunner-La Rocca: Chronic kidney disease: Clinical Aspects of Chronic Kidney Disease in Heart Failure
- 12.2: Javed Butler, Wilfried Mullens and Kevin Damman and João Pedro Ferreira: Dyskalaemia
- 12.3: Josep Masip, Karina Portillo and Mattia Arrigo: Chronic lung disease
- 12.4: Piergiuseppe Agostoni, Elisabetta Salvioni, Maria Rosa Costanzo, and Andrew JS Coats: Ventilatory Abnormalities and Sleep Disordered Breathing
- 12.5: Irene M. Lang and Stephan Rosenkranz: Pulmonary hypertension
- 12.6: Silvia Priori, Alessandro Trancuccio, Alessia Chiara Latini, Carlo Arnò, Deni Kukavica, and Andrea Mazzanti: Cardiac rhythm disorders
- 12.7: Paulus Kirchhof, Andreas Metzner, Ruben Schleberger and Douglas Packer: Management of atrial fibrillation in heart failure
- 12.8: Giuseppe Rosano, Javed Butler, Petar M. Seferovi?, Jelena Seferovic and Francesco Cosentino: Diabetes, metabolic syndrome and endocrine disorders
- 12.9: Giacomo De Luca, Luca Moroni, Alessandro Tomelleri, R Marcolongo, Lorenzo Dagna, Alida LP Caforio, and Marco Matucci-Cerinic: Systemic immune medicated diseases
- 12.10: Yuri Lopatin and Gianluigi Savarese: Liver and gut dysfunction
- 12.11: Ewa Jankowska, Piotr Ponikowski, and Stefan Anker: Anaemia and iron deficiency
- 12.12: Wolfram Doehner, Cristiana Vitale, and Mehmet Birhan Yilmaz: Depression and cognitive impairment
- 12.13: Alexander Lyon, Dimitrios Farmakis, Rudolf de Boer, and Yuri Belenkov: Cancer
- 12.14: Johann Bauersachs, Denise Hilfiker-Kleiner and Karen Sliwa: Pregnancy
- 12.15: Ewa Jankowska, Cristiana Vitale and Dong-Ju Choi: Frailty
- Section 13: Self-care and patient education
- 13.1: Tiny Jaarsma, Loreena Hill, Ekaterini Lambrinou, Anna Stromberg, and Tina Hansen: Self-care and patient education
- Section 14: Multidisciplinary approach to heart failure management
- 14.1: Loreena Hill, Friedrich Koehler, Tiny Jaarsma, Marija Polovina, Katherine...
Details
| Erscheinungsjahr: | 2024 |
|---|---|
| Fachbereich: | Chirurgie |
| Genre: | Medizin |
| Rubrik: | Wissenschaften |
| Medium: | Buch |
| Seiten: | 1040 |
| ISBN-13: | 9780198891628 |
| ISBN-10: | 0198891628 |
| Sprache: | Englisch |
| Einband: | Gebunden |
| Autor: |
Seferovic, Petar
Coats, Andrew Filippatos, Gerasimos Bauersachs, Johann Rosano, Giuseppe Anker, Stefan |
| Hersteller: | Oxford University Press, USA |
| Maße: | 277 x 244 x 66 mm |
| Von/Mit: | Petar Seferovic (u. a.) |
| Erscheinungsdatum: | 09.02.2024 |
| Gewicht: | 2,767 kg |
Warnhinweis
Ähnliche Produkte
Taschenbuch
Aktuell nicht verfügbar
Buch
Lieferzeit 2-3 Wochen
Taschenbuch
Aktuell nicht verfügbar
Taschenbuch
Aktuell nicht verfügbar
Taschenbuch
Lieferzeit 4-7 Werktage
Buch
Lieferzeit 1-2 Werktage
Taschenbuch
Lieferzeit 1-2 Werktage
Broschüre
Aktuell nicht verfügbar
Buch
Lieferzeit 1-2 Werktage
Taschenbuch
Lieferzeit 4-7 Werktage
